US2023107666A1PendingUtilityA1
Engineered 3D-Printed Artificial Axons
Assignee: MASSACHUSETTS INST TECHNOLOGYPriority: May 10, 2017Filed: Dec 7, 2022Published: Apr 6, 2023
Est. expiryMay 10, 2037(~10.8 yrs left)· nominal 20-yr term from priority
B29K 2083/00C12N 5/0622B33Y 70/00B33Y 10/00C12M 23/20C12M 25/02G01N 33/5058C12N 2539/00C12N 2535/00B29L 2031/7532B29C 64/135B29K 2033/04C12N 2533/30C08F 120/00
66
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Materials and methods for cell-mimetics having mechanical properties of biological neural axons are provided. A cell-mimetic device includes an array of fibers comprised of hexanediol diacrylate (HDDA) or an HDDA derivative, and at least one derivative of polyethylene glycol (PEG) selected from the group consisting of: PEG-acrylate, PEG-diacrylate, and any multi-arm PEG-acrylate.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A cell-mimetic device comprising:
a supporting fiber layer; and a suspended fiber layer comprising fibers supported at a defined interval by fibers of the supporting fiber layer, each of the fibers of the suspended fiber layer having an unsupported, suspended length providing for a cell-mimetic structure.
2 . The cell-mimetic device of claim 1 , wherein the unsupported, suspended length is of about 0.5 µm to about 1000 µm.
3 . The cell-mimetic device of claim 1 , wherein the unsupported, suspended length is of about 10 µm to about 200 µm.
4 . The cell-mimetic device of claim 1 , wherein the fibers of the supporting fiber layer and the suspended fiber layer are disposed in an array.
5 . The cell-mimetic device of claim 1 , wherein the fibers of the suspended fiber layer have a stiffness of between about 0.1 and 200 kPa.
6 . The cell-mimetic device of claim 1 , wherein the fibers of the suspended fiber layer have diameters between about 0.1 µm to 20 µm.
7 . The cell-mimetic device of claim 1 , wherein the fibers of the suspended fiber layer are comprised of a material comprising:
hexanediol diacrylate (HDDA) or an HDDA derivative; and at least one derivative of polyethylene glycol (PEG).
8 . The cell-mimetic device of claim 7 , wherein the at least one derivative of polyethylene glycol (PEG) is selected from the group consisting of PEG-acrylate, PEG-diacrylate, and a multi-arm PEG-acrylate.
9 . The cell-mimetic device of claim 7 , wherein the material comprises poly(HDDA-co-starPEG).
10 . The cell-mimetic device of claim 1 , wherein the fibers of the suspended fiber layer are comprised of a material comprising polydimethylsiloxane (PDMS).
11 . The cell-mimetic device of claim 1 , wherein the fibers of the suspended fiber layer are comprised of a material comprising poly(2-hydroxyethyl methacrylate) (pHEMA).
12 . The cell-mimetic device of claim 1 , wherein the fibers of the suspended fiber layer are modified by a surface ligand.
13 . A polymer ink comprising:
a base comprising hexanediol diacrylate (HDDA) or an HDDA derivative and at least one derivative of polyethylene glycol (PEG); a curing agent; and a light absorber.
14 . The polymer ink of claim 13 , wherein the at least one derivative of polyethylene glycol (PEG) is selected from the group consisting of PEG-acrylate, PEG-diacrylate, and a multi-arm PEG-acrylate.
15 . The polymer ink of claim 13 , wherein the polymer ink is configured to cure to a polymer material having a stiffness of between about 0.1 and 200 kPa.
16 . The polymer ink of claim 13 , further comprising a solvent.
17 . The polymer ink of claim 13 , wherein the polymer ink comprises about 10% w/w multi-arm PEG-acrylate and about 30% w/w HDDA.
18 . The polymer ink of claim 13 , wherein the polymer ink comprises about 10% w/w multi-arm PEG-acrylate and about 10% w/w HDDA.
19 . A material formed from curing of the polymer ink of claim 13 , the material comprising poly(HDDA-co-starPEG).
20 . A method of fabricating a cell-mimetic device comprising:
masking a resin bath with a mask defining at least a portion of a three-dimensional cell mimetic structure, the resin bath comprising hexanediol diacrylate (HDDA) or an HDDA derivative and at least one derivative of polyethylene glycol (PEG); and exposing the masked resin bath to light, an exposed portion of the masked resin bath responsively curing to a material forming the cell-mimetic device.
21 . The method of claim 20 , wherein the at least one derivative of polyethylene glycol (PEG) is selected from the group consisting of PEG-acrylate, PEG-diacrylate, and a multi-arm PEG-acrylate.
22 . The method of claim 20 , wherein masking the resin bath comprises masking the resin bath with a series of masks to define a structure of the cell-mimetic device.
23 . The method of claim 20 , wherein masking the resin bath comprises masking with a digitally-projected mask.Join the waitlist — get patent alerts
Track US2023107666A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.